These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10581042)

  • 1. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB
    Nat Genet; 1999 Dec; 23(4):481. PubMed ID: 10581042
    [No Abstract]   [Full Text] [Related]  

  • 2. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
    García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
    Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWS-FLI1 target genes recovered from Ewing's sarcoma chromatin.
    Siligan C; Ban J; Bachmaier R; Spahn L; Kreppel M; Schaefer KL; Poremba C; Aryee DN; Kovar H
    Oncogene; 2005 Apr; 24(15):2512-24. PubMed ID: 15735734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
    Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
    Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EWS-FLI1 causes neuroepithelial defects and abrogates emigration of neural crest stem cells.
    Coles EG; Lawlor ER; Bronner-Fraser M
    Stem Cells; 2008 Sep; 26(9):2237-44. PubMed ID: 18556509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of the Ewing's sarcoma phenotype by FLI1/ERF repressor hybrids.
    Athanasiou M; LeGallic L; Watson DK; Blair DG; Mavrothalassitis G
    Cancer Gene Ther; 2000 Aug; 7(8):1188-95. PubMed ID: 10975680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.
    Matsumoto Y; Tanaka K; Nakatani F; Matsunobu T; Matsuda S; Iwamoto Y
    Br J Cancer; 2001 Mar; 84(6):768-75. PubMed ID: 11259090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.
    Deneen B; Denny CT
    Oncogene; 2001 Oct; 20(46):6731-41. PubMed ID: 11709708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
    J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Caveolin-1 reduces cellular responses to TGF-beta1 through down-regulating the expression of TGF-beta type II receptor gene in NIH3T3 fibroblast cells.
    Lee EK; Lee YS; Han IO; Park SH
    Biochem Biophys Res Commun; 2007 Jul; 359(2):385-90. PubMed ID: 17543885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
    Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic serine-threonine kinase receptor-associated protein modulates the function of Ewing sarcoma protein through a novel mechanism.
    Anumanthan G; Halder SK; Friedman DB; Datta PK
    Cancer Res; 2006 Nov; 66(22):10824-32. PubMed ID: 17108118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of an adenoviral vector encoding soluble transforming growth factor-beta type II receptor to the treatment of diabetic nephropathy in mice.
    Kondo T; Takemura G; Kosai K; Ohno T; Takahashi T; Esaki M; Goto K; Maruyama R; Murata I; Minatoguchi S; Fujiwara T; Fujiwara H
    Clin Exp Pharmacol Physiol; 2008 Nov; 35(11):1288-93. PubMed ID: 18505441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer.
    Kang SH; Bang YJ; Im YH; Yang HK; Lee DA; Lee HY; Lee HS; Kim NK; Kim SJ
    Oncogene; 1999 Dec; 18(51):7280-6. PubMed ID: 10602482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M; Okita H; Hata J; Umezawa A
    Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients.
    Shin KH; Park YJ; Park JG
    Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
    Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
    Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer.
    Motomura Y; Kanbayashi H; Khan WI; Deng Y; Blennerhassett PA; Margetts PJ; Gauldie J; Egashira K; Collins SM
    Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G143-50. PubMed ID: 15297261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.